Maybe AMBS has not gone after grant money for Lympro because they know ICON is where they will get it from. Who says BP is not interested. Maybe AMBS is not interested in BP yet. BP is for commercialization after FDA approval which is some time off in the future. If they know they can prove the value through CLIA then AMBS will consider BP offers. In my opinion, it's the ones that brag about what they have that have little. It's good to be quiet and 6 weeks from now launch Lympro and PR the heck out of it. The difference is that AMBS can back the PR's up with a product that is available. The others just have PR's.